Association of Cardiologists of Bosnia & Herzegovina
The Association of Cardiologists of Bosnia & Herzegovina is a member of the European Society of Cardiology
Key information
- Number of Members: 183
- Year of Foundation: 1995
- ESC Member since: 1997
Journals
Since 2011, the Association of Cardiologists of Bosnia and Herzegovina publishes through the Medicinski Zurnal (Medical Journal) which was launched in 1994. Published every three month by the Institute for Research and Development Clinical Centre University of Sarajevo, in Bosnian, Croatian, Serbian and English, the journal has a free electronic version in English via the Institute's website.
Editor in chief: Sebija Izetbegovic
Since 2019, the Association of Cardiologists of Bosnia and Herzegovina has published the Bosnian Journal of Cardiovascular Medicine, in line with Editors Network efforts to improve publishing. It is a continuum of our work towards the ESC's main goal - "to reduce the burden of cardiovascular disease in Europe". The journal is published in English, Bosnian, Croatian and Serbian.
More information
Štrosmajerova 6, BA-71000 Sarajevo +387 61 159 009Board
Professor Mirsad Selimovic
Vice-President
Professor Belma Pojskic
President
Professor Zumreta Kusljugic
Past President
Doctor Milan Gluhovic
President of the Assembly
Doctor Malik Ejubovic
General Secretary
Professor Fahir Barakovic
Treasurer
Working Groups
Professor Sekib Sokolovic
Coronary Pathophysiology and Atherosclerosis
Associate Professor Elnur Smajic
Cardiovascular Imaging and National CVD Prevention Coordinators (NCPC)
Professor Mirsad Selimovic
Cardiometabolic Syndrome
Doctor Nerma Resic
Acute Cardiac Care
Professor Belma Pojskic
Preventive Cardiology
Assistant Professor Ekrema Mujaric
Valvular Heart Diseases
Mr Nihad Mesanovic
E-Cardiology
Professor Amra Macic-Dzankovic
Pulmonary Circulation / Right Ventricular Heart
Professor Zumreta Kusljugic
Heart Failure
Doctor Alen Karic
Cardiovascular Surgery
Doctor Mediha Kardasevic
Grown-up Congenital Heart Diseases
Assistant Professor Jelena Jovanic
Cardiovascular Imaging
Doctor Almin Handanagic
Arterial Hypertension
Doctor Boris Goronja
Cardiovascular Pacing
Assistant Professor Lamija Ferhatbegovic
Atherosclerosis
Doctor Malik Ejubovic
Young Cardiologists
Professor Larisa Dizdarevic-Hudic
Heart Failure
Assistant Professor Mugdim Bajric
Cardiovascular Pacing
ESC Clinical Practice Guidelines endorsed by your National Society
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
Our guidelines support healthcare professionals with the diagnosis and management of elevated blood pressure and hypertension.
2024 ESC Guidelines for the management of atrial fibrillation
In this iteration of the European Society of Cardiology (ESC) Clinical Practice Guidelines on Atrial Fibrillation, the task force has consolidated and evolved past approaches to develop the AF-CARE framework.
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
These guidelines provide a comprehensive framework for healthcare professionals, covering the entire PAAD patient journey.
2023 ESC Guidelines for the management of acute coronary syndromes
The present guideline has been developed to support healthcare professionals in the diagnosis and management of patients presenting with acute coronary syndrome (ACS). For the first time, the present guideline presents recommendations for management of patients across the entire spectrum of ACS in one document.
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
The current Guidelines on cardiovascular disease and diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes.
2023 ESC Guidelines for the management of endocarditis
2023 ESC Guidelines for the management of cardiomyopathies
The objective of this guideline is to help healthcare professionals diagnose and manage patients with cardiomyopathies of all ages according to the best available evidence and to provide a practical diagnostic and treatment framework for patients and their relatives.
2023 ESC Guidelines for the management of acute coronary syndromes
The present guideline has been developed to support healthcare professionals in the diagnosis and management of patients presenting with acute coronary syndrome (ACS). For the first time, the present guideline presents recommendations for management of patients across the entire spectrum of ACS in one document.
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, there have been several randomised controlled trials that should change patient management ahead of the next scheduled full guideline.
2022 ESC Guidelines on cardio-oncology
The first ESC Guidelines on cardio-oncology offer essential recommendations for protecting cardiovascular health in cancer care – supporting you at every step, from diagnosis to prevention and long-term management.
2022 ESC Guidelines on Cardiovascular Assessment and Management of Patients Undergoing Non Cardiac Surgery
These guidelines are intended for physicians, healthcare workers, and collaborators involved in the pre-operative, operative, and post-operative care of patients undergoing non-cardiac surgery.
2022 ESC Guidelines: management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
This document presents an update of the 2015 ESC Guidelines for the management of patients with ventricular arrhythmias (VA) and the prevention of sudden cardiac death (SCD).
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Pulmonary hypertension (PH) is a pathophysiological disorder, which may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases.
2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice
The present guidelines have been developed to support healthcare professionals in their efforts to reduce the burden of ASCVD in both individual patients, as well as at a population level.
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
The 2021 ESC Guidelines redefine cardiac pacing – covering CRT, His and left bundle branch pacing, advanced diagnostics, risk reduction, remote monitoring, and shared decision-making for better patient care.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence. Fortunately, we now have a wealth of clinical trials to help us select the best management to improve the outcomes for people with HF; for many, it is now both preventable and treatable.
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
These guidelines draw upon existing ESC Guidelines for the investigation, risk assessment, and management of individuals with CVD to aid physicians when prescribing exercise programmes or providing advice for sports participation.
2020 ESC Guidelines for the management of Adult Congenital Heart Disease (previously Grown-Up Congenital Heart Disease)
Decision-making in ACHD involves accurate diagnosis, timing of intervention, risk assessment, and selection of the most suitable type of intervention.
2019 Guidelines on Supraventricular Tachycardia
Our guidelines deliver updated, evidence-based recommendations for managing supraventricular tachycardias – covering drug therapy, ablation, and coexisting conditions.
2019 Guidelines on Acute Pulmonary Embolism (Diagnosis and Management of)
This document follows the previous ESC guidelines focusing on the clinical management of pulmonary embolism (PE) published in 2000, 2008, and 2014.
2019 ESC/EAS Guidelines for the management of dyslipidaemias
These ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification.
2018 Guidelines on Fourth Universal Definition of Myocardial Infarction
The 2018 ESC Guidelines refine the Universal Definition of MI – distinguishing myocardial injury from infarction with high-sensitivity biomarkers and clear clinical criteria.
2018 Guidelines for Diagnosis/Management of Syncope
Guidance on how to evaluate patients with loss of consciousness (LOC) and how to perform and interpret tests properly: tracings, videos, flow charts, and checklists are provided.